← Back to Search

Contact Lens

test/control/control for Visual Acuity

N/A
Waitlist Available
Research Sponsored by Johnson & Johnson Vision Care, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-week follow-up
Awards & highlights

Study Summary

This will be a 4-visit, randomized, controlled, single-masked, bilateral wear, dispensing, 2-treament, 2-sequence, 3-period crossover study to evalulate overall vision and comfort..

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-week follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-week follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
CLUE Comfort Score

Trial Design

2Treatment groups
Experimental Treatment
Group I: test/control/controlExperimental Treatment2 Interventions
Eligible subjects that are habitual contact lens wearers will be randomized into the (test/control/control) sequence and will wear two different study lenses one at a time bilaterally over three wear periods.
Group II: control/test/testExperimental Treatment2 Interventions
Eligible subjects that are habitual contact lens wearers will be randomized into the (control/test/test) sequence and will wear two different study lenses one at a time bilaterally over three wear periods.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
soft contact lens in senofilcon A (C3) with HEVL-blocking chromophore
2022
N/A
~130
ACUVUE OASYS 1-Day for Astigmatism
2022
N/A
~280

Find a Location

Who is running the clinical trial?

Johnson & Johnson Vision Care, Inc.Lead Sponsor
216 Previous Clinical Trials
25,435 Total Patients Enrolled
87 Trials studying Visual Acuity
8,650 Patients Enrolled for Visual Acuity
Johnson & Johnson Vision Care, Inc. Clinical TrialStudy DirectorJohnson & Johnson Vision Care, Inc.
44 Previous Clinical Trials
4,309 Total Patients Enrolled
33 Trials studying Visual Acuity
3,679 Patients Enrolled for Visual Acuity

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~43 spots leftby Apr 2025